Gleneagles Hospital Hong Kong, part of the IHH Healthcare network, has entered into a strategic partnership with the Asian Venous Academy and Dr Smile Medical Group to advance collaboration in venous disease related services, research and education.
The partnership will promote academic exchange, enhance clinical practice, support medical education and drive innovation, including the application of artificial intelligence in venous care. The shared goal is to elevate standards of care and improve patient outcomes across the region.
Dr Kenneth Tsang, Regional CEO of IHH Healthcare North Asia and CEO of Gleneagles Hospital Hong Kong, highlighted that the collaboration will leverage Hong Kong’s strengths in clinical research and international standards. It will also provide a platform to support the global expansion of clinical skills, medical technologies and innovative therapies developed by Chinese Mainland companies.
Through structured academic exchange and multidisciplinary clinical collaboration, the initiative aims to deepen professional expertise in venous disease care while strengthening regional and international partnerships.
Related Stories
Fortis Healthcare Hosts 1st Annual Neuro-conclave Mumbai 2026
Fortis Healthcare marked the successful conclusion of the 1st Annual Neuro-conclave Mumbai 2026, held on 21 and 22 March, showcasing the strength and integration of its neuroscience team.
IHH Malaysia Supports 10KM Category at Penang Bridge International Marathon
IHH Malaysia is the 10KM title sponsor for the upcoming Penang Bridge International Marathon 2026 (PBIM), encouraging individuals of all fitness levels to embrace a more active lifestyle.
IHH Singapore Recognised for Contributions to SGSHARE Initiative
IHH Singapore was recognised by Community Chest Singapore at the SG60 Appreciation Ceremony on 7 March 2026 for our contributions to the SGSHARE initiative.
Enhancing Patient Journeys at Pantai Hospital Melaka
Restoring the Gift of Hearing at Gleneagles Hospital Kuala Lumpur
Gleneagles Hong Kong Partners with Emerging Viral Diagnostics and Mannings to Expand Community Healthcare
Gleneagles Hong Kong has joined forces with Emerging Viral Diagnostics (EVDL) and Mannings to create an innovative community healthcare ecosystem, combining advanced diagnostics, healthcare expertise, and accessible community channels.
